SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001193125-10-042893
Filing Date
2010-02-26
Accepted
2010-02-26 16:07:51
Documents
11
Period of Report
2009-12-31
Filing Date Changed
2010-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2171772
2 REVISED DIRECTOR COMPENSATION POLICY dex1020.htm EX-10.20 11714
3 FORM OF EQUITY/LONG-TERM INCENTIVE AWARD AGREEMENT FOR DIRECTORS dex1022.htm EX-10.22 29534
4 FORM OF EQUITY/LONG-TERM INCENTIVE AWARD AGREEMENT FOR EMPLOYEES dex1023.htm EX-10.23 29719
5 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 18589
6 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 986
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1642
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 7132
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 7410
10 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex32.htm EX-32 6292
11 GRAPHIC g59505g82a40.jpg GRAPHIC 62374
  Complete submission text file 0001193125-10-042893.txt   2372295
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12465 | Film No.: 10639337
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1